Q1 EPS Forecast for Privia Health Group Reduced by Analyst

Privia Health Group, Inc. (NASDAQ:PRVA) – Analysts at Leerink Partnrs cut their Q1 2025 earnings estimates for Privia Health Group in a research report issued on Thursday, February 27th. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $0.07 per share for the quarter, down from their prior estimate of $0.08. The consensus estimate for Privia Health Group’s current full-year earnings is $0.14 per share. Leerink Partnrs also issued estimates for Privia Health Group’s Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.09 EPS, FY2025 earnings at $0.33 EPS, Q1 2026 earnings at $0.10 EPS, Q2 2026 earnings at $0.11 EPS, Q3 2026 earnings at $0.12 EPS, Q4 2026 earnings at $0.13 EPS and FY2027 earnings at $0.61 EPS.

A number of other analysts have also issued reports on the stock. JMP Securities restated a “market outperform” rating and issued a $26.00 price target on shares of Privia Health Group in a research note on Friday, February 14th. Needham & Company LLC lifted their price target on shares of Privia Health Group from $25.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. Macquarie started coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target for the company. JPMorgan Chase & Co. lifted their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. Finally, Canaccord Genuity Group lifted their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. One analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $26.47.

Privia Health Group Trading Up 2.2 %

NASDAQ PRVA opened at $25.52 on Monday. The company’s fifty day simple moving average is $22.61 and its 200-day simple moving average is $20.68. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $26.04. The stock has a market cap of $3.06 billion, a P/E ratio of 255.23, a PEG ratio of 3.47 and a beta of 0.87.

Hedge Funds Weigh In On Privia Health Group

Several hedge funds and other institutional investors have recently modified their holdings of PRVA. Creative Planning boosted its holdings in shares of Privia Health Group by 27.1% during the third quarter. Creative Planning now owns 25,987 shares of the company’s stock valued at $473,000 after acquiring an additional 5,542 shares during the period. International Assets Investment Management LLC boosted its holdings in shares of Privia Health Group by 1,720.9% during the third quarter. International Assets Investment Management LLC now owns 5,499 shares of the company’s stock valued at $100,000 after acquiring an additional 5,197 shares during the period. Olympiad Research LP acquired a new position in shares of Privia Health Group during the third quarter valued at $195,000. GSA Capital Partners LLP boosted its holdings in shares of Privia Health Group by 228.1% during the third quarter. GSA Capital Partners LLP now owns 50,975 shares of the company’s stock valued at $928,000 after acquiring an additional 35,439 shares during the period. Finally, Victory Capital Management Inc. boosted its holdings in shares of Privia Health Group by 402.9% during the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock valued at $3,260,000 after acquiring an additional 143,446 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.